Capital Goods Healthcare Sector

Pharmadrug

Market Cap: CA$1.1m

Operates as a specialty pharmaceutical company.

Panacea Life Sciences Holdings

Market Cap: US$776.8k

Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets.

MediXall Group

Market Cap: US$774.9k

Provides health solutions in the United States.

Ovation Science

Market Cap: CA$1.1m

Engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States.

GRI Bio

Market Cap: US$761.8k

A clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States.

Tevano Systems Holdings

Market Cap: CA$1.0m

A technology holding company, engages in the development and operation of software and online applications.

Empatho Holdings

Market Cap: CA$1.0m

Operates as a virtual well-being company in Canada.

CBD Life Sciences

Market Cap: US$735.0k

Engages in the development and marketing a line of cannabidiol based organic products.

Ayujoy Herbals

Market Cap: US$733.4k

A research and testing organization, provides technical and regulatory consulting for biotechnical products, pharmaceuticals, diagnostics, medical equipment, and devices.

cbdMD

Market Cap: US$732.0k

Produces and distributes various cannabidiol (CBD) products in the United States.

Onconetix

Market Cap: US$729.9k

A biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology.

Maple Leaf Green World

Market Cap: US$717.7k

Does not have significant operations.

Nutra Pharma

Market Cap: US$710.0k

A biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States.

Steep Hill

Market Cap: CA$970.7k

Does not have significant operations.

Avenue Therapeutics

Market Cap: US$693.2k

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases.

Cognetivity Neurosciences

Market Cap: CA$935.6k

Operates as a technology company.

CareSpan Health

Market Cap: CA$952.3k

Operates as a healthcare technology and services company in the United States.

Nexien BioPharma

Market Cap: US$686.5k

Focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States.

Viracta Therapeutics

Market Cap: US$675.7k

A clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide.

TC Biopharm (Holdings)

Market Cap: US$673.0k

A clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform.

Grapefruit USA

Market Cap: US$664.0k

Operates as a manufacturer and distributor of cannabis products in California.

Trend Exploration

Market Cap: US$655.1k

Trend Exploration, Inc engages in the supply of products for medical, dental, and veterinary communities.

Sonendo

Market Cap: US$649.6k

A commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.

Jetblack

Market Cap: US$649.0k

Does not have significant operations.

MindBio Therapeutics

Market Cap: CA$889.8k

Operates as a clinical stage drug development company in Australasia.

Vitalibis

Market Cap: US$631.3k

Operates as a technology-based formulator of phytocannabinoid rich hemp products with cannabidiol, along with personal care and nutritional products.

HAVN Life Sciences

Market Cap: CA$859.4k

A biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi.

Biora Therapeutics

Market Cap: US$630.3k

A clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States.

EvokAI Creative Labs

Market Cap: CA$874.6k

A MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.

Newtopia

Market Cap: CA$866.3k

Operates as a tech-enabled whole health platform primarily in the United States.

Lumiera Health

Market Cap: CA$849.8k

Develops and commercializes evidence-based botanical products for the healthcare in Canada.

Theralink Technologies

Market Cap: US$615.1k

A commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States.

Lophos Holdings

Market Cap: CA$858.6k

Through its subsidiaries, engages in the cultivation and research of peyote cactus.

Itonis

Market Cap: US$609.4k

A development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases.

nDatalyze

Market Cap: CA$826.5k

Provides technology-based health-related solutions in Canada, the United States, and internationally.

EGF Theramed Health

Market Cap: CA$813.2k

Engages in the development of psychedelic drugs for the treatment of mental health problems in Canada.